...
首页> 外文期刊>Annals of Intensive Care >Concurrent initiation of intra-aortic balloon pumping with extracorporeal membrane oxygenation reduced in-hospital mortality in postcardiotomy cardiogenic shock
【24h】

Concurrent initiation of intra-aortic balloon pumping with extracorporeal membrane oxygenation reduced in-hospital mortality in postcardiotomy cardiogenic shock

机译:体外膜氧合同时开始主动脉内球囊反搏减少了心切开性心源性休克的住院死亡率

获取原文

摘要

Abstract BackgroundVeno-arterial extracorporeal membrane oxygenation (VA-ECMO) is widely used in postcardiotomy cardiac shock (PCS). The factors that affect mortality in patients who receive ECMO for PCS remain unclear. In this study, we analyzed the outcomes, predictive factors and complications of ECMO use for PCS.MethodsA total of 152 adult subjects who received VA-ECMO for PCS in Fuwai Hospital were consecutively included. We retrospectively collected the baseline characteristics, outcomes and complications. Baseline characteristics were compared between survivors with non-survivors, and logistic regression was performed to identify predictive factors for in-hospital mortality.ResultsThe mean age of the subjects was 49.5?±?14.1?years, with a male dominancy of 73.7%. The main surgical procedures were heart transplantation (32.2%), coronary artery bypass graft (17%) and valvular surgery (11.8%). Intra-aortic balloon pumping (IABP) was initiated concurrently with ECMO in 32.2% subjects and sequentially in 18.4% subjects. The ECMO weaning rate was 56.6%, and the in-hospital mortality was 52.0%. When compared with non-survivors, survivors had less hypertension (15.1% vs. 35.4%, p =?0.004), secondary thoracotomy before ECMO initiation (19.2% vs. 39.2%, p =?0.007), pre-ECMO cardiac arrest/ventricular fibrillation (11.0% vs. 34.2%, p =?0.001), bedside implantation of ECMO (11.0% vs. 41.8%, p ?0.001), and more transplant procedure (45.2% vs. 20.3%, p =?0.001), concurrent IABP initiation with ECMO (41.1% vs. 24.1%, p =?0.025). Multivariate logistic regression indicated concurrent IABP initiation with ECMO was the only independent protective factor for in-hospital mortality (OR?=?0.375, p =?0.041, 95% CI 0.146–0.963). Concurrent IABP initiation with ECMO had less need for continuous renal replacement therapy (30.6% vs. 49.3%, p =?0.039) and less neurological complications (8.2% vs. 22.7%, p =?0.035), but more thrombosis complications (18.4% vs. 2.7%, p =?0.007).ConclusionConcurrent initiation of IABP with ECMO provides better short-term survival for PCS, with reduced peripheral perfusion complications.
机译:摘要背景静脉动脉体外膜氧合作用(VA-ECMO)被广泛用于开颅手术性心脏休克(PCS)。对于接受PCS ECMO的患者,影响死亡率的因素仍不清楚。在这项研究中,我们分析了PCS ECMO使用的结局,预测因素和并发症。方法总共包括152名在阜外医院接受PCS VA-ECMO的成年受试者。我们回顾性地收集了基线特征,结果和并发症。比较了幸存者和非幸存者的基线特征,并进行了逻辑回归分析以确定院内死亡率的预测因素。结果受试者的平均年龄为49.5±14.1岁,男性占73.7%。主要手术方法为心脏移植(32.2%),冠状动脉搭桥术(17%)和瓣膜手术(11.8%)。在32.2%的受试者中,与ECMO同时开始主动脉内球囊抽吸(IABP),随后在18.4%的受试者中开始。 ECMO的断奶率为56.6%,住院死亡率为52.0%。与非幸存者相比,幸存者的高血压发生率更低(15.1%vs. 35.4%,p =?0.004),ECMO开始前的继发性开胸手术(19.2%vs. 39.2%,p =?0.007),ECMO前心脏骤停/心室纤颤(11.0%对34.2%,p = 0.001),床旁ECMO植入(11.0%对41.8%,p <0.001)和更多的移植手术(45.2%对20.3%,p = 0.001) ),同时使用ECMO发起IABP(41.1%对24.1%,p =?0.025)。多元logistic回归表明,ECMO并发IABP是住院死亡率的唯一独立保护因素(OR == 0.375,p =?0.041,95%CI 0.146-0.963)。 IABP与ECMO并发的患者较少需要持续进行肾脏替代治疗(30.6%vs. 49.3%,p =?0.039),神经系统并发症也较少(8.2%vs. 22.7%,p =?0.035),但血栓形成并发症更多(18.4) %vs. 2.7%,p =?0.007)。结论使用ECMO同时启动IABP可为PCS提供更好的短期生存,并减少外周灌注并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号